Cancer Therapeutics Training (CT2) Talk | David Tyvoll, PhD and Kyle Bohnert, PhD
bis
Comer Commons, Moores Cancer Center, Kalifornien
The Development of Pharmaceutical Inhibitors of the IRE1a/XBP1s Arm of the Unfolded Protein Response to Prevent Skeletal Muscle Loss During Cancer Cachexia David Tyvoll, PhD is a physical chemist. He completed his undergraduate degree at UCSD, earned his PhD at Stanford as well as completed post-doctoral work. He also completed additional graduate work at UCLA. He worked for Hewlett Packard and Silverbrook Research, and most recently at the Alfred Mann Institute for Biomedical Engineering at USC. Kyle Bohnert, PhD completed his undergraduate degree at Hanover College, then earned a master’s degree in Biomechanics from the University of Kentucky, followed by a PhD in Anatomical Sciences and Neurobiology from the University of Louisville. He is currently an Associate Professor at St. Ambrose University in Iowa, where he teaches Gross Anatomy and Kinesiology. His work on cancer cachexia established the rationale for this research effort.